Urinary Incontinence
Urinary incontinence treatment costs and effect on quality of life were analyzed
Published in Women's Health Weekly, March 23rd, 2006
Investigators in Germany conducted a study "to describe the characteristics, of women seeking treatment for symptoms of urinary incontinence (UI) in European countries."
"Prospective urinary incontinence research (PURE) was a 6-month, observational, pan-European Study, primarily aimed at determining the direct costs of urinary incontinence treatment," explained D. Sykes and colleagues of Eli Lilly and Company Limited. The secondary objectives of PURE were to describe the impact of UI on health-related quality of life (HRQoL) in treatment seeking patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Implants
Breast implants were not shown to increase long-term breast cancer risk - Cervical Cancer
Human papillomavirus tissue affinity may contribute to carcinogenic potential - Fibroids
Fibroids have low recurrence rates after laparoscopic uterine artery occlusion - HIV/AIDS Transmission
HIV-1 acquisition may be increased by vaginal washing practice in African women - Menopause
Soybean phytoestrogens may have very limited benefit on bone health - Andropause
QuatRx Pharmaceuticals Company initiates phase II trial of fispemifene for andropause - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
